Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

INVIVYD, INC.

(IVVD)
  Report
Delayed Nasdaq  -  04:00 2022-12-01 pm EST
2.210 USD   -2.21%
11/17Invivyd Says it Teamed Up With Population Health Partners to Accelerate Clinical Development Projects
MT
11/17Invivyd, Inc. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Other Events, Financial Statements and Exhibits (form 8-K)
AQ
11/17Invivyd Announces Partnership With Population Health Partners to Accelerate Clinical Development in Infectious Diseases Including COVID-19
GL
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
ETFs positioned on INVIVYD, INC.ETFs and Trackers with Trackinsight
ETF WeightVar. 5daysRatingGeography
Virtus LifeSci Biotech Clinical Trials ETF - USD0.72%1.84%United_States
ETFMG Treatments Testing and Advancements E...0.42%1.90%-NC
ALPS Medical Breakthroughs ETF - USD0.22%2.79%United_States
IShares Micro-Cap ETF - USD0.04%0.63%United_States
Vanguard Russell 2000 Value ETF - USD0.01%0.98%United_States
IShares Russell 2000 Value ETF - USD0.01%1.18%United_States
IShares Russell 2000 ETF - USD0.01%-1.27%United_States
Xtrackers Russell 2000 1C - USD0.01%0.02%United_States
Vanguard Russell 2000 ETF - USD0.01%1.11%United_States
Schwab U.S. Small-Cap ETF - USD0.01%1.31%United_States
Vanguard Small-Cap Growth ETF - USD0%-1.02%United_States
Vanguard Small Cap ETF - USD0%-0.90%United_States
Vanguard Small-Cap Value ETF - USD0%1.12%United_States
Vanguard FTSE Global All Cap ex Canada Inde...0%2.34%World



Copyright ę 2009 Morningstar. All Rights Reserved. The information, data and opinions expressed (ôInformationö) and contained herein: (1) are proprietary to Morningstar and/or its content providers and are not intended to represent investment advice or recommendation to buy or sell any security; (2) may not be copied or distributed without express license to do so; and (3) are not warranted to be accurate, complete or timely. Morningstar reserve its rights to charge for access to these Ratings and/or Rating report. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this Rating, Rating Report or Information contained therein.
Chart INVIVYD, INC.
Duration : Period :
Invivyd, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus UNDERPERFORM
Number of Analysts 4
Last Close Price 2,26 $
Average target price 3,83 $
Spread / Average Target 69,6%
Chart INVIVYD, INC.
Duration : Period :
Invivyd, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Sector and Competitors
1st jan.Capi. (M$)
INVIVYD, INC.-68.87%246
VERTEX PHARMACEUTICALS46.07%81 217
REGENERON PHARMACEUTICALS, INC.19.03%80 283
BIONTECH SE-34.26%40 589
WUXI APPTEC CO., LTD.-34.22%32 137
GENMAB A/S24.30%29 594